ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 109 filers reported holding ANI PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,206,951 | +157.1% | 20,788 | +75.9% | 0.00% | – |
| Q1 2023 | $469,490 | -55.9% | 11,820 | -55.3% | 0.00% | – |
| Q4 2022 | $1,063,963 | +63.4% | 26,447 | +87.4% | 0.00% | – |
| Q4 2021 | $651,000 | +59.2% | 14,114 | +0.3% | 0.00% | – |
| Q4 2020 | $409,000 | -0.5% | 14,067 | +120.4% | 0.00% | -100.0% |
| Q4 2017 | $411,000 | -47.8% | 6,382 | -72.7% | 0.00% | -80.0% |
| Q1 2016 | $788,000 | +89.9% | 23,395 | +154.3% | 0.01% | +66.7% |
| Q4 2015 | $415,000 | -51.0% | 9,200 | -32.0% | 0.00% | -57.1% |
| Q1 2015 | $847,000 | +112.3% | 13,539 | -4.0% | 0.01% | +75.0% |
| Q3 2014 | $399,000 | -66.6% | 14,096 | -59.3% | 0.00% | -73.3% |
| Q2 2014 | $1,193,000 | +187.5% | 34,637 | +161.7% | 0.02% | +200.0% |
| Q1 2014 | $415,000 | – | 13,235 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |